Argenx

ARGX NASDAQ
133.79
+7.86
+6.24%
已收盘, 16:00 06/18 EDT
开盘
127.71
昨收
125.93
最高
133.90
最低
127.69
成交量
18.02万
成交均量(3M)
17.25万
52周最高
137.50
52周最低
63.81
换手率
0.48%
市值
50.43亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Argenx ARGX股票价格,Argenx股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.
展开 >

最近浏览

名称
价格
涨跌幅